We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3323:HKEXChina National Building Material Co. Ltd. Class H Analysis

Data as of 2026-03-15 - not real-time

NT$35.40

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Celxpert Energy is trading near its twenty‑day moving average, with the fifty‑day and two‑hundred‑day averages clustered closely, indicating a flat price landscape. The fourteen‑day RSI hovers in the mid‑forties, suggesting neither strong buying nor selling pressure, while the MACD shows a bearish divergence that could foreshadow a downside move. The fair‑value estimate from discounted cash‑flow analysis sits well below the current market price, highlighting a significant valuation gap. Volatility over the past month is elevated, and trading volume has been on a downward trend, which together raise concerns about price stability. Despite a modest dividend yield, the company reports negative earnings, thin margins and a negative free cash flow, casting doubt on the sustainability of the payout.
Sector dynamics for battery and energy‑storage equipment remain supportive in the long run, yet the firm’s recent revenue contraction and weak profitability undermine its near‑term outlook. The beta close to market neutrality suggests price movements are largely driven by company‑specific factors rather than broader market swings. With a high drawdown history and a debt‑to‑equity ratio that, while not extreme, adds financial pressure, the stock appears overvalued at current levels. Investors should weigh the overvaluation against the sector’s growth potential and the company’s ability to reverse its earnings trend.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • bearish MACD signal
  • price above fair‑value estimate
  • declining trading volume

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • flat technical trend
  • sector demand for battery packs
  • ongoing earnings weakness

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • potential industry tailwinds
  • need for earnings turnaround
  • valuation gap remains large

Key Metrics & Analysis

Financial Health

Revenue Growth-18.60%
Profit Margin-3.69%
ROE-6.78%
ROA-2.38%
Debt/Equity31.86
P/B Ratio1.4
Op. Cash FlowNT$81.5M
Free Cash FlowNT$-723183104
Industry P/E29.1

Technical Analysis

TrendNeutral
RSI43.1
SupportNT$32.30
ResistanceNT$44.60
MA 20NT$37.09
MA 50NT$38.96
MA 200NT$38.94
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueNT$12.81
GradeOvervalued
TypeValue
Dividend Yield1.41%

Risk Assessment

Beta0.97
Volatility58.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.